About BTG Pharmaceuticals
BTG is a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. Improving patients’ quality of life and offering hope is what motivates and inspires us. BTG was acquired by SERB Pharmaceuticals in 2020. SERB now operates in the US as BTG Pharmaceuticals.
- Employees
- 350
Leadership
The top of BTG Pharmaceuticals's org chart, with how many people report into each leader.
Anthony Higham
CEO
25 reports
Sam Elcomb
Vp, Quality
6 reports
Thomas Kolaras
Executive Vp, Chief Commercial Officer US
4 reports
Ben Watt
Chief Financial Officer
3 reports
Arthur Pignot
Chief Strategy Officer
2 reports
Antoine Bernasconi
Executive Vp, Chief Commercial Officer Europe & International
1 report
Vincent Sainte - Catherine
Chief Operations Officer, EMEA
1 report
Marie Botin
Chief HR Officer
Christon Hill
Chief Innovation Officer
Jobs at BTG Pharmaceuticals
No open positions right now. Explore more companies on TheJobsMap.